The reduction in price target by a reputable analyst like Larry Biegelsen could lead to a short-term negative sentiment among investors, potentially causing a decrease in the stock price of Inari Medical. The Overweight rating suggests a positive long-term outlook, but the lowered price target indicates a revision of the expected performance level, which might impact investor confidence in the short term.